Clinical Trials Logo
  1. Home
  2. Spinal Cord Injury, Acute
  3. NCT03505463

The Neuroinflammatory Response and Biomarkers in Acute Traumatic Spinal Cord Injury

Spinal Cord Injury, Acute Clinical Trial

Official title:
The Neuroinflammatory Response and Biomarkers in Acute Traumatic Spinal Cord Injury: A Pilot Study

Clinical Trial Summary

The study is a prospective cohort study designed to assess the diagnostic and prognostic potential of biomarker measurement in acute traumatic spinal cord injury (TSCI), and to examine the neuroinflammatory response to acute TSCI.

Clinical Trial Description

TSCI is an incurable condition with devastating consequences. The physical, psychosocial and financial implications in addition to a variable recovery and an uncertain prognosis have a profound impact on quality of life.The pathophysiology of TSCI is dual consisting of a primary injury and a secondary injury. The immediate trauma to the spinal cord and nerve roots causes the primary injury, while a prolonged cascade of events causes the secondary injury. The neuroinflammatory response is considered to be an important event. Current clinical measures to evaluate acute TSCI consist of clinical examination and routine imaging modalities. These measurements are inaccurate to assess injury severity, prognosis, and therapeutic efficacy, especially in the early acute phase. Biomarker measurement may provide a more accurate measure. This study aim to assess the diagnostic and prognostic potential of biomarker measurement in acute TSCI, and to examine the neuroinflammatory response to acute TSCI. To achieve this, immune cells, cytokines, autoantibodies and structural proteins will be analysed in blood and cerebrospinal fluid by Flow Cytometry and assay techniques. These analyses will be correlated to clinical outcome assessed according to international standards. Hopefully, this will contribute with new knowledge of the neuroinflammatory response and biomarkers in acute TSCI, and provide the needed knowledge for conducting futures trials in novel therapeutic interventions. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03505463
Study type Observational
Source University of Aarhus
Contact
Status Active, not recruiting
Phase
Start date May 1, 2018
Completion date December 1, 2020
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04812431 - Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI Phase 1/Phase 2
Enrolling by invitation NCT05047120 - Hypnotic Cognitive Therapy Reduce Acute & Chronic SCI Pain in Inpatient Rehabilitation N/A
Completed NCT03707704 - Quality Control of a Strengthening Protocol in Subjects With Spinal Cord Injury
Completed NCT03935321 - NISCI - Nogo Inhibition in Spinal Cord Injury Phase 2
Recruiting NCT03965299 - Transcutaneous Tibial Nerve Stimulation in Acute Spinal Cord Injury N/A
Recruiting NCT04064385 - Functional Electrical Stimulation Cycling in SCI N/A
Completed NCT01889940 - Effectiveness of Psycho-emotional Support in Acute Spinal Cord Injury. ESPELMA Project N/A
Recruiting NCT05693181 - Cord Blood Cells in Patients With Acute SCI Phase 1/Phase 2
Terminated NCT03083366 - Sacral Nerve Stimulation in Improving Bladder Function After Acute Traumatic Spinal Cord Injury N/A
Recruiting NCT02991690 - Systemic Hypothermia in Acute Cervical Spinal Cord Injury N/A
Completed NCT03661294 - Investigating the Energy Expenditure of Acute Spinal Cord Injured Patients N/A